Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology
Patent
2000-01-18
2000-12-12
Elliott, George C.
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of regulating cell metabolism or physiology
435 6, 536 231, 536 241, 536 245, 514 44, C07H 2104, A61K 4800, C12Q 168
Patent
active
061597341
ABSTRACT:
Antisense compounds, compositions and methods are provided for modulating the expression of Peroxisome proliferator-activated receptor gamma. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Peroxisome proliferator-activated receptor gamma. Methods of using these compounds for modulation of Peroxisome proliferator-activated receptor gamma expression and for treatment of diseases associated with expression of Peroxisome proliferator-activated receptor gamma are provided.
REFERENCES:
patent: 5686596 (1997-11-01), Mukherjee
patent: 5814647 (1998-09-01), Urban et al.
patent: 5902726 (1999-05-01), Kliewer et al.
Berger et al., Novel Peroxisome Proliferator-activated Receptor (PPAR) gamma and PPARdelta Ligands Produce Distinct Biological Effects, J. Biol. Chem., 1999, 274:6718-6725.
Brun et al., Peroxisome proliferator-activated receptor gamma and the control of adipogenesis, Curr. Opin. Lipidol., 1997, 8:212-218.
Elbrecht et al., L-764406 is a partial agonist of human peroxisome proliferator-activated receptor gamma. The role of Cys313 in ligand binding, J. Biol. Chem., 1999, 274:7913-7922.
Forman et al., 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma, Cell, 1995, 83:803-812.
Greene et al., Isolation and cloning of human peroxisome proliferator activated receptor gamma cDNA, Adv. Exp. Med. Biol., 1997, 253-260.
Greene et al., Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping, Gene Expr., 1995, 4:281-299.
Hu et al., Transdifferentiation of mybolasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha, Proc. Natl. Acad. Sci. U. S. A., 1995, 92:9856-9860.
Huang et al., Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase, Nature, 1999, 400:378-382.
Jiang et al., PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines, Nature, 1998, 391:82-86.
Kitamura et al., Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains, Biochem. Biophys. Res. Commun., 1999, 254:582-586.
Kliewer et al., A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation, Cell, 1995, 83:813-819.
Kubota et al., Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo, Cancer Res., 1998, 58:3344-3352.
Lefebvre et al., Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice, Nat. Med., 1998, 4:1053-1057.
Lehmann et al., An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma), J. Biol. Chem., 1995, 270:12953-12956.
Mizukami et al., The antidiabetic agent thiazolidinedione stimulates the interaction between PPAR gamma and CBP, Biochem. Biophys. Res. Commun., 1997, 240:61-64.
Mueller et al., Terminal differentiation of human breast cancer through PPAR gamma, Mol. Cell, 1998, 1:465-470.
Murakami et al., A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats, Diabetes, 1998, 47:1841-1847.
Palmer et al., cis-parinaric acid is a ligand for the human peroxisome proliferator activated receptor gamma: development of a novel spectrophotometric assay for the discovery of PPARgamma ligands, FEBS Lett., 1998, 431:476-480.
Reginato et al., A potent antidiabetic thiazolidinedione with unique pereoxisome proliferator-activated receptor gamma-activating properties, J. Biol. Chem., 1998, 273:32679-32684.
Ricote et al., Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein, Proc. Natl. Acad. Sci. U. S. A., 1998, 95:7614-7619.
Ricote et al., The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation, Nature, 1998, 391:79-82.
Saez et al., Activators of the nuclear receptor PPARgamma enhance colon polyp formation, Nat. Med., 1998, 4:1058-1061.
Sarraf et al., Differentiation and reversal of malignant changes in colon cancer through PPARgamma [see comments], Nat. Med., 1998, 4:1046-1052.
Sarraf et al., Loss-of-function mutations in PPAR gamma associated with human colon cancer, Mol. Cell., 1999, 3:799-804.
Shao et al., Peroxisome proliferator activated receptor gamma, CCAAT/enhancer-binding protein alpha, and cell cycle status regulate the commitment to adipocyte differentiation, J. Biol. Chem., 1997, 272:21472-21478.
Spiegelman, PPAR-gamma: adipogenic regulator and thiazolidinedione receptor, Diabetes, 1998, 47:507-514.
Su et al., A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response, J. Clin. Invest., 1999, 104:383-389.
Tontonoz et al., Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor, Cell, 1994, 79:1147-1156.
Tontonoz et al., Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma, Curr. Opin. Genet. Dev., 1995, 5:571-576.
Tontonoz et al., Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor, Proc. Natl. Acad. Sci. U. S. A., 1997, 94:237-241.
Baker Brenda F.
Borchers Alexander H.
McKay Robert
Elliott George C.
ISIS Pharmaceuticals Inc.
McGarry Sean
LandOfFree
Antisense modulation of peroxisome proliferator-activated recept does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense modulation of peroxisome proliferator-activated recept, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense modulation of peroxisome proliferator-activated recept will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-215726